Markets.com Logo

KTOV

$--
--%
1d
1w
1m

Analysis and statistics

  • Open
    1.2942$
  • Previous Close
    1.2879$
  • 52 Week Change
    8.60$
  • Day Range
    0.01$
  • 52 Week High/Low
    1$ - 9.6$
  • Dividend Per Share
    0
  • Market cap
    227 M$
  • EPS
    --
  • Beta
    2.0447
  • Volume
    --

About

KTOV.TA refers to Kitov Pharma Ltd., an Israeli biopharmaceutical company that develops and commercializes innovative therapies for unmet medical needs, primarily focusing on cancer and pain management. The ".TA" suffix indicates that this stock is traded on the Tel Aviv Stock Exchange.

Gold's Safe-Haven Status Under Scrutiny: Market Dynamics and Price Outlook

Emma Rose|--

Trump's Iran War Exit Without a Deal: Reshaping Middle East Energy Security and Power Dynamics

Emma Rose|--
European market insights: What is the European stock market doing right now?

European market insights: What is the European stock market doing right now?

Ghko B|--
EUR/USD Analysis Today: EUR/USD Gains to 1.1550 as Middle East Uncertainty Lingers

EUR/USD Analysis Today: EUR/USD Gains to 1.1550 as Middle East Uncertainty Lingers

Ghko B|--

Microsoft at a Crossroads: AI Hurdles and Cloud Resilience Amidst Market Volatility

Sophia Claire|--

Iran's Hormuz Gambit: Leveraging a Chokepoint for Economic Leverage and Global Impact

Ava Grace|--

Gold Market Resilience: Navigating Sell-offs and Sustaining Bull Run

Noah Lee|--

Factors

[Company Performance]: KTOV.TA's price hinges on Kitov Pharma's (the underlying company) clinical trial results, drug approvals, and commercialization success. Positive outcomes generally boost the stock. [Market Sentiment]: Overall investor mood and risk appetite significantly impact KTOV.TA. Positive market trends often lift even speculative stocks, while negative sentiment can drag them down. [Regulatory Environment]: Changes in pharmaceutical regulations, approval processes, or healthcare policies in relevant markets can directly affect Kitov Pharma's potential and, consequently, the stock price. [Competition]: The competitive landscape within Kitov Pharma's therapeutic areas influences investor perception. The emergence of competing drugs or technologies may negatively affect KTOV.TA. [Financial Health]: Kitov Pharma's cash position, debt levels, and ability to fund ongoing research and development are vital. Financial stability strengthens investor confidence. [Macroeconomic Factors]: Broad economic conditions, such as interest rates, inflation, and economic growth, can indirectly affect KTOV.TA by influencing investor behavior and investment decisions.

People Also Watch

Latest news

US Steel and Aluminum Tariffs Revamped: Simplification Amidst Potential Cost Increases

Noah Lee|--

SpaceX Files Secret IPO Bid, Eyeing Record-Breaking $1.75 Trillion Valuation

Ava Grace|--

US Intelligence: Iran Unwilling to Engage in Substantive Talks to End War

Sophia Claire|--

Latest Education Articles

What Is Sensex in Stock Market: Meaning, Calculation, and Why It Matters for Investors

What Is Sensex in Stock Market: Meaning, Calculation, and Why It Matters for Investors

Ghko B|--
Investing basics for beginners: What are the 4 economic indicators?

Investing basics for beginners: What are the 4 economic indicators?

Frances Wang|--
CFDs vs Options: What’s the Difference?

CFDs vs Options: What’s the Difference?

Julian Parker|--